SecBot SecBot
Institutional Cluster

CADL

Candel Therapeutics, Inc.
NEUTRAL
Impact 4/10
Horizonweeks Processed2mo ago
Institutional cluster: 13 buyers, 2 sellers (bullish)
Actionable Insight • Neutral

The institutional cluster is overwhelmingly passive/index-driven, not conviction-based. With no insider buying to corroborate the thesis and a divergent 13F × Form 4 signal, the accumulation is likely mechanical rebalancing rather than a fundamental call. Monitor for active-manager filings (e.g., hedge fund 13Fs) in the next cycle to gauge genuine conviction. The Q4 2026 BLA submission remains the primary catalyst.

DirectionNeutral
Confidencemedium
Horizonweeks
Latest settled — T+20d
CADL ▼ -8.55% at T+20d
NEUTRAL call -8.55% · α vs SPY -6.58% · entry $12.16 → $11.12
Next anchor: T+60d in 13d
Latest observation: T+48 -41.31% FF3 residual α
Entry = T+0 close
Aug 15, 2026
via day close
T+1d
-0.90%
call -0.90% · α -0.23%
$12.05
settled 2mo ago
T+5d
+5.76%
call +5.76% · α +6.95%
$12.86
settled 2mo ago
T+20d
-8.55%
call -8.55% · α -6.58%
$11.12
settled 6w ago
T+60d
Pending
in 13d

Executive Summary

A strong institutional cluster formed in CADL during Q2 2026, with 13 buyers accumulating $83.4M in net new positions (total holdings $108.9M) against negligible selling of $932. The buying was dominated by mega-passive funds (State Street, BlackRock, Geode) who collectively added ~$79.6M, likely reflecting index rebalancing or increased benchmark weighting following the stock's significant appreciation. The cluster aligns with the company's Q2 2026 earnings report filed 2 days ago, which highlighted a widening net loss but a strong cash position and on-track BLA submission for aglatimagene in Q4 2026. The heavy passive buying and lack of insider open-market purchases (confluence score 21/100, divergent) suggest the institutional moves are largely mechanical rather than conviction-driven, limiting the signal's alpha potential.

Key Financial Metrics

Direction
accumulating
Buy Value
$108.9M
Sell Value
$932.00
Net Flow
$83.4M

Institutional Positions

Net institutional flow: $83.4M

▲ Buyers (13)

InstitutionActionChangePosition ValueValue Δ
State StreetDOUBLED+333.7%$36.6M$32.6M
BlackRockADD+59.8%$51.2M$35.9M
GeodeADD+51.7%$16.2M$11.1M

▼ Sellers (2)

InstitutionActionChangePrev ValueValue Δ
Optiver Holding B.v.TRIM-34%$2.0K$759.00
Pnc Financial Services GroupTRIM-41.6%$754.00$173.00

Key Facts

  • 13 institutional buyers added $83.4M in net new CADL positions during Q2 2026, with total buyer holdings reaching $108.9M
  • Only 2 sellers trimmed negligible positions totaling $932, indicating near-unanimous accumulation direction
  • Mega-passive funds (State Street +$32.6M, BlackRock +$35.9M, Geode +$11.1M) accounted for ~96% of total buying value
  • No open-market insider buying was detected, and the 13F × Form 4 confluence score was a divergent 21/100
  • The cluster follows Q2 2026 earnings (net loss $38.9M, cash $201.6M) and the upcoming Q4 2026 BLA submission for aglatimagene in prostate cancer

Financial Impact

13 institutions accumulated $83.4M in net new positions (total buyer holdings $108.9M) while 2 sellers reduced holdings by a negligible $932

institutional_ownershipfloat_percentage

Risk Factors

  • Passive-dominated buying may reverse if CADL is dropped from indices or if the stock's weighting is reduced
  • No insider buying suggests management is not signaling confidence at current valuation
  • Q2 2026 net loss widened significantly to $38.9M, and the company remains pre-revenue with binary BLA risk

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
87% bullish (15 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-CADL-2026-Q2
21 reports for CADL
Performance horizon
100% Hit rate @ T+60 4 of 4 directional calls Went positive at some point 6 of 6 best @ T+60▲ +67.70%Mar 17, 2026
Filters
Rows
Reports for CADL — sortable, filterable
TypeNow
Oct 1, 2026
25d ago
Press Release
BULLISH ★ 7/10
$10.16awaiting T+60——
Sep 30, 2026
26d ago
Press Release
NEUTRAL ★ 4/10
$10.44awaiting T+60——
Sep 10, 2026
6w ago
8-K
NEUTRAL ★ 4/10
$11.33awaiting T+60——
Sep 9, 2026
6w ago
8-K
NEUTRAL ★ 4/10
$11.33awaiting T+60——
Aug 15, 2026
10w ago
Institutional Cluster
NEUTRAL ★ 4/10
$12.16awaiting T+60——
Aug 13, 2026
10w ago
8-K
NEUTRAL ★ 4/10
$11.80awaiting T+60——
Aug 13, 2026
10w ago
Press Release
BULLISH ★ 7/10
$11.80awaiting T+60——
Aug 3, 2026
12w ago
Press Release
NEUTRAL ★ 2/10
$10.07awaiting T+60——
Jul 1, 2026
16w ago
Insider Cluster
NEUTRAL ★ 3/10
$9.83 $11.19▲ +13.84%▲ +11.04%—
Jul 1, 2026
16w ago
Insider Cluster
NEUTRAL ★ 2/10
$9.83 $11.19▲ +13.84%▲ +11.04%—
Showing 10 of 21

US Market Status

Market Closed — Opens Wed (11h 53m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 15, 2026